117 related articles for article (PubMed ID: 38874041)
21. Intravoxel incoherent motion diffusion-weighted imaging for discriminating the pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Lu W; Jing H; Ju-Mei Z; Shao-Lin N; Fang C; Xiao-Ping Y; Qiang L; Biao Z; Su-Yu Z; Ying H
Sci Rep; 2017 Aug; 7(1):8496. PubMed ID: 28819296
[TBL] [Abstract][Full Text] [Related]
22. Attention mechanism based multi-sequence MRI fusion improves prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Zhou X; Yu Y; Feng Y; Ding G; Liu P; Liu L; Ren W; Zhu Y; Cao W
Radiat Oncol; 2023 Oct; 18(1):175. PubMed ID: 37891611
[TBL] [Abstract][Full Text] [Related]
23. Deep learning-based radiomic features for improving neoadjuvant chemoradiation response prediction in locally advanced rectal cancer.
Fu J; Zhong X; Li N; Van Dams R; Lewis J; Sung K; Raldow AC; Jin J; Qi XS
Phys Med Biol; 2020 Apr; 65(7):075001. PubMed ID: 32092710
[TBL] [Abstract][Full Text] [Related]
24. Evaluating treatment response to neoadjuvant chemoradiotherapy in rectal cancer using various MRI-based radiomics models.
Li Z; Ma X; Shen F; Lu H; Xia Y; Lu J
BMC Med Imaging; 2021 Feb; 21(1):30. PubMed ID: 33593304
[TBL] [Abstract][Full Text] [Related]
25. Predicting the Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Using Soluble Immune Checkpoints.
Ari A; Sevik H; Sevinc MM; Tatar C; Buyukasik K; Surel AA; Idiz UO
Cancer Biother Radiopharm; 2024 Apr; 39(3):247-254. PubMed ID: 38010745
[No Abstract] [Full Text] [Related]
26. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
[TBL] [Abstract][Full Text] [Related]
27. [Expression of CD133 in rectal cancer tissues and its relationship with neoadjuvant chemoradiotherapy].
Li D; Wu H; Feng R; Zhong D; Luo Y; Xiao Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jun; 19(6):690-4. PubMed ID: 27353106
[TBL] [Abstract][Full Text] [Related]
28. Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemoradiotherapy: A comparison of morphological, volumetric and functional MRI parameters.
Hötker AM; Tarlinton L; Mazaheri Y; Woo KM; Gönen M; Saltz LB; Goodman KA; Garcia-Aguilar J; Gollub MJ
Eur Radiol; 2016 Dec; 26(12):4303-4312. PubMed ID: 26945761
[TBL] [Abstract][Full Text] [Related]
29. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
[TBL] [Abstract][Full Text] [Related]
30. Comparison of (18)F-FDG PET/CT methods of analysis for predicting response to neoadjuvant chemoradiation therapy in patients with locally advanced low rectal cancer.
Altini C; Niccoli Asabella A; De Luca R; Fanelli M; Caliandro C; Quartuccio N; Rubini D; Cistaro A; Montemurro S; Rubini G
Abdom Imaging; 2015 Jun; 40(5):1190-202. PubMed ID: 25348731
[TBL] [Abstract][Full Text] [Related]
31. Complete Response Evaluation of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiotherapy Using Textural Features Obtained from T2 Weighted Imaging and ADC Maps.
Azamat S; Karaman Ş; Azamat IF; Ertaş G; Kulle CB; Keskin M; Sakin RND; Bakır B; Oral EN; Kartal MG
Curr Med Imaging; 2022; 18(10):1061-1069. PubMed ID: 35240976
[TBL] [Abstract][Full Text] [Related]
32. MRI features and texture analysis for the early prediction of therapeutic response to neoadjuvant chemoradiotherapy and tumor recurrence of locally advanced rectal cancer.
Park H; Kim KA; Jung JH; Rhie J; Choi SY
Eur Radiol; 2020 Aug; 30(8):4201-4211. PubMed ID: 32270317
[TBL] [Abstract][Full Text] [Related]
33. The value of multimodality MR in T staging evaluation after neoadjuvant therapy for rectal cancer.
Liu B; Sun C; Zhao X; Liu L; Liu S; Ma H
Technol Health Care; 2024; 32(2):615-627. PubMed ID: 37393447
[TBL] [Abstract][Full Text] [Related]
34. Predictive value of modified MRI-based split scar sign (mrSSS) score for pathological complete response after neoadjuvant chemoradiotherapy for patients with rectal cancer.
Yuan Y; Zheng K; Zhou L; Chen F; Zhang S; Lu H; Lu J; Shao C; Meng R; Zhang W; Gao X; Shen F
Int J Colorectal Dis; 2023 Feb; 38(1):40. PubMed ID: 36790595
[TBL] [Abstract][Full Text] [Related]
35. A Pattern-Based Approach Combining Tumor Morphology on MRI With Distinct Signal Patterns on Diffusion-Weighted Imaging to Assess Response of Rectal Tumors After Chemoradiotherapy.
Lambregts DMJ; Delli Pizzi A; Lahaye MJ; van Griethuysen JJM; Maas M; Beets GL; Bakers FCH; Beets-Tan RGH
Dis Colon Rectum; 2018 Mar; 61(3):328-337. PubMed ID: 29369900
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic performance of magnetic resonance imaging in preoperative local staging of rectal cancer after neoadjuvant chemoradiotherapy.
Çelik H; Barlık F; Sökmen S; Terzi C; Canda AE; Sağol Ö; Sarıoğlu S; Ünlü M; Bilkay Görken İ; Arıcan Alıcıkuş Z; Öztop İ
Diagn Interv Radiol; 2023 Mar; 29(2):219-227. PubMed ID: 36971272
[TBL] [Abstract][Full Text] [Related]
37. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy.
Park MJ; Kim SH; Lee SJ; Jang KM; Rhim H
Radiology; 2011 Sep; 260(3):771-80. PubMed ID: 21846762
[TBL] [Abstract][Full Text] [Related]
38. CT-based radiomic features to predict pathological response in rectal cancer: A retrospective cohort study.
Yuan Z; Frazer M; Zhang GG; Latifi K; Moros EG; Feygelman V; Felder S; Sanchez J; Dessureault S; Imanirad I; Kim RD; Harrison LB; Hoffe SE; Frakes JM
J Med Imaging Radiat Oncol; 2020 Jun; 64(3):444-449. PubMed ID: 32386109
[TBL] [Abstract][Full Text] [Related]
39. A deep neural network predictor to predict the sensitivity of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Liu Y; Shi J; Liu W; Tang Y; Shu X; Wang R; Chen Y; Shi X; Jin J; Li D
Cancer Lett; 2024 May; 589():216641. PubMed ID: 38232812
[TBL] [Abstract][Full Text] [Related]
40. A Comprehensive Prediction Model Based on MRI Radiomics and Clinical Factors to Predict Tumor Response After Neoadjuvant Chemoradiotherapy in Rectal Cancer.
Jiang H; Guo W; Yu Z; Lin X; Zhang M; Jiang H; Zhang H; Sun Z; Li J; Yu Y; Zhao S; Hu H
Acad Radiol; 2023 Sep; 30 Suppl 1():S185-S198. PubMed ID: 37394412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
